{"id":1872,"date":"2025-07-31T08:02:13","date_gmt":"2025-07-31T05:02:13","guid":{"rendered":"https:\/\/www.technology-asgard.com\/?p=1872"},"modified":"2025-08-08T11:00:18","modified_gmt":"2025-08-08T08:00:18","slug":"molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox","status":"publish","type":"post","link":"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/","title":{"rendered":"FOX &#8211; Molecule of THC-Lysergic Acid: Synthesis, Predicted Clinical Effects, and Medical Value Named after Megan Fox"},"content":{"rendered":"\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><strong>Author \u2013 Denys Sukhachov<\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><strong>Molecule of THC-Lysergic Acid: Synthesis, Predicted Clinical Effects, and Medical Value<br><br><br>Named after Megan Fox<\/strong><\/p>\n\n\n\n<p><strong>Author \u2013 Denys Sukhachov<\/strong><\/p>\n\n\n\n<h1 class=\"wp-block-heading\"><\/h1>\n\n\n\n<h2 class=\"wp-block-heading\">Introduction<\/h2>\n\n\n\n<p>Tetrahydrocannabinol (THC) and lysergic acid are compounds renowned for their psychoactive and therapeutic properties. THC, the primary active component of cannabis, interacts with the endocannabinoid system, while lysergic acid, a derivative of ergot alkaloids, forms the basis of LSD and targets serotonin receptors. Combining these molecules via a biocompatible polyethylene glycol (PEG) linker into a hybrid structure, named THC-PEG-Lys, could unlock novel pharmacological opportunities, particularly in pain management, psychiatric disorders, and neurological conditions. This article outlines the theoretical design, synthesis, predicted clinical effects, and potential medical value of the THC-PEG-Lys conjugate, emphasizing the safety and stability provided by the PEG linker.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Chemical Structure and Molecular Design<\/h2>\n\n\n\n<p>The hybrid THC-PEG-Lys molecule is created by covalently linking THC (C\u2082\u2081H\u2083\u2080O\u2082) and lysergic acid (C\u2081\u2086H\u2081\u2086N\u2082O\u2082) through a polyethylene glycol (PEG) linker. The key functional groups involved are:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>THC<\/strong>: Hydroxyl group (-OH) on the phenolic ring (C1 of the benzopyran structure).<\/li>\n\n\n\n<li><strong>Lysergic Acid<\/strong>: Carboxyl group (-COOH) at the C8 position of the ergot alkaloid system.<\/li>\n\n\n\n<li><strong>PEG Linker<\/strong>: A di-functional PEG (e.g., PEG-dicarboxylic acid, HOOC-(CH\u2082CH\u2082O)\u2099-COOH) serves as a biocompatible linker to connect the two molecules, reducing steric hindrance and enhancing stability.<\/li>\n<\/ul>\n\n\n\n<p>The PEG linker (e.g., PEG-4 with a molecular weight of ~194 g\/mol) forms ester bonds with both THC and lysergic acid, resulting in a theoretical molecular formula of C\u2083\u2087H\u2085\u2080N\u2082O\u2087 and a molecular weight of approximately 740.72 g\/mol. The use of PEG ensures biocompatibility, water solubility, and controlled release of the active components.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Synthesis of the Hybrid Molecule<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Reaction<\/h3>\n\n\n\n<p>The synthesis of THC-PEG-Lys involves esterification reactions to conjugate THC and lysergic acid via a PEG linker:<br>[<br>\\ce{C21H30O2-OH + HOOC-(CH2CH2O)n-COOH + HOOC-C16H16N2O2 -&gt; C21H30O2-O-(CH2CH2O)n-CO-C16H16N2O2 + 2H2O}<br>]<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Reaction Conditions<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Reagents<\/strong>: Purified THC, lysergic acid, and PEG-dicarboxylic acid (e.g., PEG-4).<\/li>\n\n\n\n<li><strong>Catalyst<\/strong>: N,N&#8217;-Dicyclohexylcarbodiimide (DCC) and 4-dimethylaminopyridine (DMAP).<\/li>\n\n\n\n<li><strong>Solvent<\/strong>: Dichloromethane (CH\u2082Cl\u2082) to maintain an anhydrous environment.<\/li>\n\n\n\n<li><strong>Conditions<\/strong>: Temperature 0\u201325\u00b0C, inert atmosphere (nitrogen).<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Synthesis Steps<\/h3>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li><strong>Reagent Preparation<\/strong>: THC is extracted from cannabis, and lysergic acid is obtained from ergotamine or synthesized.<\/li>\n\n\n\n<li><strong>First Esterification<\/strong>: The carboxyl group of PEG-dicarboxylic acid is activated with DCC to form an O-acylisourea intermediate, which reacts with the hydroxyl group of THC in the presence of DMAP to form an ester bond.<\/li>\n\n\n\n<li><strong>Second Esterification<\/strong>: The remaining carboxyl group of the PEG linker is activated similarly and reacts with the carboxyl group of lysergic acid (or a modified hydroxyl\/amine group if necessary).<\/li>\n\n\n\n<li><strong>Purification<\/strong>: The product is purified using column chromatography (silica gel, eluent: hexane\/ethyl acetate).<\/li>\n\n\n\n<li><strong>Characterization<\/strong>: The structure is confirmed using NMR spectroscopy, mass spectrometry, and IR spectroscopy.<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\">Molecular Weight Calculation<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>THC<\/strong>: C\u2082\u2081H\u2083\u2080O\u2082 = (21 \u00d7 12.01) + (30 \u00d7 1.008) + (2 \u00d7 16.00) = 314.45 g\/mol.<\/li>\n\n\n\n<li><strong>Lysergic Acid<\/strong>: C\u2081\u2086H\u2081\u2086N\u2082O\u2082 = (16 \u00d7 12.01) + (16 \u00d7 1.008) + (2 \u00d7 14.01) + (2 \u00d7 16.00) = 268.31 g\/mol.<\/li>\n\n\n\n<li><strong>PEG-4<\/strong>: Approximately 194 g\/mol (for n=4).<\/li>\n\n\n\n<li><strong>Water Loss<\/strong>: Two ester bonds result in the loss of 2 \u00d7 H\u2082O = 2 \u00d7 18.02 = 36.04 g\/mol.<\/li>\n\n\n\n<li><strong>Total Molecular Weight<\/strong>: 314.45 + 268.31 + 194 \u2212 36.04 = <strong>740.72 g\/mol<\/strong>.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Challenges<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Stability<\/strong>: While PEG enhances stability compared to direct ester bonds, enzymatic cleavage in vivo may release THC and lysergic acid, requiring further optimization.<\/li>\n\n\n\n<li><strong>Regulatory Issues<\/strong>: THC and lysergic acid are controlled substances, complicating their use in laboratory settings.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Predicted Clinical Effects<\/h2>\n\n\n\n<p>The THC-PEG-Lys conjugate is expected to combine the pharmacological effects of its components, targeting:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Endocannabinoid Receptors (CB1\/CB2)<\/strong>: The THC component may provide analgesic, antiemetic, and anti-inflammatory effects, beneficial for chronic pain, chemotherapy-induced nausea, and epilepsy.<\/li>\n\n\n\n<li><strong>Serotonin Receptors (5-HT2A)<\/strong>: The lysergic acid component may modulate psychoemotional states, potentially useful for depression, anxiety, or post-traumatic stress disorder (PTSD).<\/li>\n\n\n\n<li><strong>Synergistic Effects<\/strong>: The combination may enhance therapeutic outcomes through modulation of neurotransmitters like dopamine and serotonin, with PEG enabling controlled release to mitigate acute psychoactive effects.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Potential Risks<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Psychoactivity<\/strong>: The combination of THC and lysergic acid may induce strong psychoactive effects, necessitating precise dosing.<\/li>\n\n\n\n<li><strong>Pharmacokinetics<\/strong>: Enzymatic cleavage of the PEG linker in vivo could lead to unpredictable release of THC and lysergic acid, complicating therapeutic profiles.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Medical Value<\/h2>\n\n\n\n<p>The THC-PEG-Lys conjugate has potential applications in:<\/p>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li><strong>Chronic Pain Management<\/strong>: The analgesic properties of THC combined with the psychoactive modulation of lysergic acid may be effective for neuropathic pain.<\/li>\n\n\n\n<li><strong>Psychiatric Disorders<\/strong>: Potential treatment for depression, anxiety, or PTSD, where psychoactive compounds have shown promise (Kupfer et al., 2016).<\/li>\n\n\n\n<li><strong>Neurological Conditions<\/strong>: Possible use in epilepsy or neurodegenerative diseases due to THC\u2019s neuroprotective properties (Hampson et al., 2000).<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\">Advantages<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Multitarget Action<\/strong>: Simultaneous effects on endocannabinoid and serotonin systems.<\/li>\n\n\n\n<li><strong>Biocompatibility<\/strong>: PEG enhances water solubility and reduces toxicity, improving drug delivery.<\/li>\n\n\n\n<li><strong>Controlled Release<\/strong>: The PEG linker may allow gradual release of active components, reducing acute psychoactive effects.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Limitations<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Regulatory Barriers<\/strong>: The controlled status of THC and lysergic acid hinders research and clinical use.<\/li>\n\n\n\n<li><strong>Research Needs<\/strong>: Preclinical and clinical trials are essential to evaluate safety, efficacy, and pharmacokinetics.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Safety Considerations<\/h2>\n\n\n\n<p>PEG is a biocompatible and non-toxic linker widely used in pharmaceuticals (e.g., pegylated interferons). It enhances the conjugate\u2019s stability and solubility while reducing the risk of hydrolysis compared to direct ester bonds. However, careful monitoring of psychoactive effects and metabolic cleavage is necessary to ensure safety.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Conclusions<\/h2>\n\n\n\n<p>The THC-PEG-Lys conjugate, formed by linking THC and lysergic acid via a PEG linker, offers a promising approach for pharmacological research due to its potential synergy between endocannabinoid and serotonin systems. With a theoretical molecular weight of 740.72 g\/mol and formula C\u2083\u2087H\u2085\u2080N\u2082O\u2087, the molecule can be synthesized through esterification under controlled conditions. The use of PEG enhances safety and bioavailability, making it suitable for potential applications in chronic pain, psychiatric disorders, and neurological conditions. However, further preclinical and clinical studies are required to confirm its safety, efficacy, and pharmacokinetic profile.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">References<\/h2>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li>Hampson, A. J., Grimaldi, M., Axelrod, J., &amp; Wink, D. (2000). Cannabidiol and (\u2212)\u03949-tetrahydrocannabinol are neuroprotective antioxidants. <em>Proceedings of the National Academy of Sciences<\/em>, 95(14), 8268\u20138273.<\/li>\n\n\n\n<li>Kupfer, D. J., Frank, E., &amp; Phillips, M. L. (2016). Major depressive disorder: new clinical, neurobiological, and treatment perspectives. <em>The Lancet<\/em>, 379(9820), 1045\u20131055.<\/li>\n\n\n\n<li>Mechoulam, R., &amp; Parker, L. A. (2013). The endocannabinoid system and the brain. <em>Annual Review of Psychology<\/em>, 64, 21\u201347.<\/li>\n\n\n\n<li>Nichols, D. E. (2016). Psychedelics. <em>Pharmacological Reviews<\/em>, 68(2), 264\u2013355.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Author \u2013 Denys Sukhachov Molecule of THC-Lysergic Acid: Synthesis, Predicted Clinical Effects, and Medical Value Named after Megan Fox Author \u2013 Denys Sukhachov Introduction Tetrahydrocannabinol (THC) and lysergic acid are compounds renowned for their psychoactive and therapeutic properties. THC, the primary active component of cannabis, interacts with the endocannabinoid system, while lysergic acid, a derivative of ergot alkaloids, forms the basis of LSD and targets serotonin receptors. Combining these molecules via a biocompatible polyethylene glycol (PEG) linker into a hybrid [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1870,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[26],"tags":[],"class_list":["post-1872","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-research"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>FOX - Molecule of THC-Lysergic Acid: Synthesis, Predicted Clinical Effects, and Medical Value Named after Megan Fox - Asgard Technology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FOX - Molecule of THC-Lysergic Acid: Synthesis, Predicted Clinical Effects, and Medical Value Named after Megan Fox - Asgard Technology\" \/>\n<meta property=\"og:description\" content=\"Author \u2013 Denys Sukhachov Molecule of THC-Lysergic Acid: Synthesis, Predicted Clinical Effects, and Medical Value Named after Megan Fox Author \u2013 Denys Sukhachov Introduction Tetrahydrocannabinol (THC) and lysergic acid are compounds renowned for their psychoactive and therapeutic properties. THC, the primary active component of cannabis, interacts with the endocannabinoid system, while lysergic acid, a derivative of ergot alkaloids, forms the basis of LSD and targets serotonin receptors. Combining these molecules via a biocompatible polyethylene glycol (PEG) linker into a hybrid [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/\" \/>\n<meta property=\"og:site_name\" content=\"Asgard Technology\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-31T05:02:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-08T08:00:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.technology-asgard.com\/wp-content\/uploads\/2025\/07\/4a4a588bfdf5e69d44537712d248e399.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"736\" \/>\n\t<meta property=\"og:image:height\" content=\"552\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Asgard Technology\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Asgard Technology\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/\",\"url\":\"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/\",\"name\":\"FOX - Molecule of THC-Lysergic Acid: Synthesis, Predicted Clinical Effects, and Medical Value Named after Megan Fox - Asgard Technology\",\"isPartOf\":{\"@id\":\"https:\/\/www.technology-asgard.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.technology-asgard.com\/wp-content\/uploads\/2025\/07\/4a4a588bfdf5e69d44537712d248e399.jpg\",\"datePublished\":\"2025-07-31T05:02:13+00:00\",\"dateModified\":\"2025-08-08T08:00:18+00:00\",\"author\":{\"@id\":\"https:\/\/www.technology-asgard.com\/#\/schema\/person\/7a9fadfd46fd8502fd6a6bb8371d0a19\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/#primaryimage\",\"url\":\"https:\/\/www.technology-asgard.com\/wp-content\/uploads\/2025\/07\/4a4a588bfdf5e69d44537712d248e399.jpg\",\"contentUrl\":\"https:\/\/www.technology-asgard.com\/wp-content\/uploads\/2025\/07\/4a4a588bfdf5e69d44537712d248e399.jpg\",\"width\":736,\"height\":552,\"caption\":\"Style: \\\"C1-cosmo\\\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0413\u043e\u043b\u043e\u0432\u043d\u0430\",\"item\":\"https:\/\/www.technology-asgard.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FOX &#8211; Molecule of THC-Lysergic Acid: Synthesis, Predicted Clinical Effects, and Medical Value Named after Megan Fox\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.technology-asgard.com\/#website\",\"url\":\"https:\/\/www.technology-asgard.com\/\",\"name\":\"Asgard Technology\",\"description\":\"Asgard for a better future\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.technology-asgard.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.technology-asgard.com\/#\/schema\/person\/7a9fadfd46fd8502fd6a6bb8371d0a19\",\"name\":\"Asgard Technology\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.technology-asgard.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/www.technology-asgard.com\/wp-content\/uploads\/2024\/12\/sloj-4.svg\",\"contentUrl\":\"https:\/\/www.technology-asgard.com\/wp-content\/uploads\/2024\/12\/sloj-4.svg\",\"caption\":\"Asgard Technology\"},\"sameAs\":[\"https:\/\/www.technology-asgard.com\"],\"url\":\"https:\/\/www.technology-asgard.com\/en\/author\/asgard_0727\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FOX - Molecule of THC-Lysergic Acid: Synthesis, Predicted Clinical Effects, and Medical Value Named after Megan Fox - Asgard Technology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/","og_locale":"en_US","og_type":"article","og_title":"FOX - Molecule of THC-Lysergic Acid: Synthesis, Predicted Clinical Effects, and Medical Value Named after Megan Fox - Asgard Technology","og_description":"Author \u2013 Denys Sukhachov Molecule of THC-Lysergic Acid: Synthesis, Predicted Clinical Effects, and Medical Value Named after Megan Fox Author \u2013 Denys Sukhachov Introduction Tetrahydrocannabinol (THC) and lysergic acid are compounds renowned for their psychoactive and therapeutic properties. THC, the primary active component of cannabis, interacts with the endocannabinoid system, while lysergic acid, a derivative of ergot alkaloids, forms the basis of LSD and targets serotonin receptors. Combining these molecules via a biocompatible polyethylene glycol (PEG) linker into a hybrid [&hellip;]","og_url":"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/","og_site_name":"Asgard Technology","article_published_time":"2025-07-31T05:02:13+00:00","article_modified_time":"2025-08-08T08:00:18+00:00","og_image":[{"width":736,"height":552,"url":"https:\/\/www.technology-asgard.com\/wp-content\/uploads\/2025\/07\/4a4a588bfdf5e69d44537712d248e399.jpg","type":"image\/jpeg"}],"author":"Asgard Technology","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Asgard Technology","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/","url":"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/","name":"FOX - Molecule of THC-Lysergic Acid: Synthesis, Predicted Clinical Effects, and Medical Value Named after Megan Fox - Asgard Technology","isPartOf":{"@id":"https:\/\/www.technology-asgard.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/#primaryimage"},"image":{"@id":"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/#primaryimage"},"thumbnailUrl":"https:\/\/www.technology-asgard.com\/wp-content\/uploads\/2025\/07\/4a4a588bfdf5e69d44537712d248e399.jpg","datePublished":"2025-07-31T05:02:13+00:00","dateModified":"2025-08-08T08:00:18+00:00","author":{"@id":"https:\/\/www.technology-asgard.com\/#\/schema\/person\/7a9fadfd46fd8502fd6a6bb8371d0a19"},"breadcrumb":{"@id":"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/#primaryimage","url":"https:\/\/www.technology-asgard.com\/wp-content\/uploads\/2025\/07\/4a4a588bfdf5e69d44537712d248e399.jpg","contentUrl":"https:\/\/www.technology-asgard.com\/wp-content\/uploads\/2025\/07\/4a4a588bfdf5e69d44537712d248e399.jpg","width":736,"height":552,"caption":"Style: \"C1-cosmo\""},{"@type":"BreadcrumbList","@id":"https:\/\/www.technology-asgard.com\/en\/molecule-of-thc-lysergic-acid-synthesis-predicted-clinical-effects-and-medical-value-named-after-megan-fox\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0413\u043e\u043b\u043e\u0432\u043d\u0430","item":"https:\/\/www.technology-asgard.com\/en\/"},{"@type":"ListItem","position":2,"name":"FOX &#8211; Molecule of THC-Lysergic Acid: Synthesis, Predicted Clinical Effects, and Medical Value Named after Megan Fox"}]},{"@type":"WebSite","@id":"https:\/\/www.technology-asgard.com\/#website","url":"https:\/\/www.technology-asgard.com\/","name":"Asgard Technology","description":"Asgard for a better future","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.technology-asgard.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.technology-asgard.com\/#\/schema\/person\/7a9fadfd46fd8502fd6a6bb8371d0a19","name":"Asgard Technology","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.technology-asgard.com\/#\/schema\/person\/image\/","url":"https:\/\/www.technology-asgard.com\/wp-content\/uploads\/2024\/12\/sloj-4.svg","contentUrl":"https:\/\/www.technology-asgard.com\/wp-content\/uploads\/2024\/12\/sloj-4.svg","caption":"Asgard Technology"},"sameAs":["https:\/\/www.technology-asgard.com"],"url":"https:\/\/www.technology-asgard.com\/en\/author\/asgard_0727\/"}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/www.technology-asgard.com\/wp-content\/uploads\/2025\/07\/4a4a588bfdf5e69d44537712d248e399.jpg","_links":{"self":[{"href":"https:\/\/www.technology-asgard.com\/en\/wp-json\/wp\/v2\/posts\/1872"}],"collection":[{"href":"https:\/\/www.technology-asgard.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.technology-asgard.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.technology-asgard.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.technology-asgard.com\/en\/wp-json\/wp\/v2\/comments?post=1872"}],"version-history":[{"count":3,"href":"https:\/\/www.technology-asgard.com\/en\/wp-json\/wp\/v2\/posts\/1872\/revisions"}],"predecessor-version":[{"id":1980,"href":"https:\/\/www.technology-asgard.com\/en\/wp-json\/wp\/v2\/posts\/1872\/revisions\/1980"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.technology-asgard.com\/en\/wp-json\/wp\/v2\/media\/1870"}],"wp:attachment":[{"href":"https:\/\/www.technology-asgard.com\/en\/wp-json\/wp\/v2\/media?parent=1872"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.technology-asgard.com\/en\/wp-json\/wp\/v2\/categories?post=1872"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.technology-asgard.com\/en\/wp-json\/wp\/v2\/tags?post=1872"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}